Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063776 | 0.79 | GABRA1 (0.42) | — | |
| SCHEMBL5035207 | 0.79 | CYP19A1 (0.42) | — | |
| SCHEMBL7461135 | 0.77 | TDP1 (0.38) | — | |
| SCHEMBL1253891 | 0.76 | CYP1A1 (0.33) | CYP1A1CYP1A2CYP1B1PYCR1 | |
| SCHEMBL29456692 | 0.76 | GABRA1 (0.46) | PYCR1 | |
| SCHEMBL4953056 | 0.76 | GABRA1 (0.46) | PYCR1 | |
| SCHEMBL9862093 | 0.75 | HSPA5 (0.40) | CYP1A1CYP1A2CYP1B1PYCR1 | |
| SCHEMBL21401412 | 0.75 | ADH1B (0.47) | — | |
| SCHEMBL4170188 | 0.73 | TRPA1 (0.36) | CYP1A1CYP1A2CYP1B1PYCR1 | |
| SCHEMBL29566515 | 0.71 | TAAR1 (0.46) | CYP1A2PYCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210198208-A1 | 4-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES | PURDUE RESEARCH FOUNDATION (US) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210198208-A1 | 4-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES | MCL1, ABL1, FLT3 | CYP1A1 1470/4885CYP1A2 847/4885CYP1B1 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.